Price movement over the last 24 hours
ACM Research Inc vs Ascendis Pharma A/S — how do they compare? ACM Research Inc trades at $99.61 (market cap $6.54B), while Ascendis Pharma A/S trades at $277.16 (market cap $17.51B). The key difference: Ascendis Pharma A/S is far larger — about 2.7× ACM Research Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, ACM Research Inc nearer its low. Which is the better fit depends on your goals.
| ACMR | ASND | |
|---|---|---|
Market Cap | $6.54B | $17.51B |
Sector | Technology | Health |
52-Week High | $126.89 | $274.50 |
52-Week Low | $23.92 | $163.32 |
Enterprise Value | $5.61B | $17.88B |
Trailing returns across standard periods
ACM Research develops and manufactures semiconductor process equipment, specializing in wafer cleaning and electroplating solutions. Its tools are used by global chipmakers to improve productivity and yield for logic and memory chips.
Read more on ACMR →Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →